That is very important, because the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work. To put it simply, we need to understand how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (longtime readers). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. This was an advancement practically no one discovered. However it's going to have profound ramifications for treating illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be a lot of investment chances in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (exponential growth). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back possibly substantially prior to going greater - biotech stock. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were primarily educating readers. However that's not the huge concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. democratic republic. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of great personal business on the edge of hitting the general public markets And I've been working on a new method for you to invest even before these companies go public.
This opportunity has actually been developing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to reserve your spot for totally free.
Emma Walsh here, managing editor of the Journal. Regular Diary readers understand that tech isn't our typical beat (jeff brown biotech pick). And when it pertains to tech investing, we leave it to the specialists. Fortunately, we have several such professionals in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing specialists we know (jeff brown biotech pick). In fact, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and forecast what's simply around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These trends are experiencing exponential development and creating incredible chances for investors. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown 2021 predictions. But regardless of what numerous readers might think, this is a trend that's simply getting begun. Although the COVID-19 pandemic disrupted supply chains in 2015, a remarkable 250 million 5G-enabled devices were still sold.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown 2021 predictions). Losing 2 months of manufacturing and sales truly affects the number of 5G devices are offered in the calendar year. When you consider all of that, offering 250 million systems is impressive. More importantly, the hold-ups triggered by the pandemic created a heap of pent-up need. And that need is now going to be pressed into 2021. In truth, I anticipate that more than 500 million 5G devices will be shipped in 2021 - toxic tech 5 tech darlings. Which's not my only 5G prediction When I have actually talked about 5G in the past, I've explained its 3 various phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Stage Three, 5G services begin to be used (biotech stocks jeff brown). That's when we begin to see applications operating on 5G networks. Think about things like huge multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Phase Three by this summer season. This begins something of a virtuous cycle: Many people don't really care about the innovation. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open a suite of incredible applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment chances going forward will be enormous. Stepping far from 5G, the next crucial technology I visualize in 2021 is CRISPR genetic modifying. CRISPR represents "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not work properly. CRISPR utilizes a similar idea however with our hereditary code. "Typos" in our genome can result in disease. CRISPR can fix these "typos." For many years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And throughout that time, there were actually just 3 business operating in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating illness and seeing that this technology simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire industry is efficiently a greenfield chance.
There's space for lots of business to exist in this space. diplomatic relations. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or 3 more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things occurring at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can properly forecast the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is essential since the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error process. Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but a number of drug therapies produced using this technology. This was among those breakthroughs that nearly no one noticed. But it's going to have profound ramifications for treating illness. And, obviously, there will be lots of investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe significantly before going greater. I have actually been covering bitcoin for a long period of time now. One of the very first research reports I ever published was on bitcoin - jeff brown genome sequencing. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my recommendation. But at the time of that preliminary recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. jeff brown genetic sequencer stock. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information is up to date as of February 2021, but we might not independently validate this claim. Provided Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this moment. Brown is best known for his sage-like capability to choose winning innovation stocks. He invested more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an exceptional perspective on the marketplace. He's constantly on the hunt for new chances, and he shares many of his finest choices in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he successfully anticipated a few of the biggest financial events of the past 20 years. Although he doesn't appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it ideal each time, however Jeff Brown's precise forecasts have actually made him legions of dedicated followers. That says a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular financial research publisher. Brownstone Research study provides a number of research study services with a wide range of expertises - jeff brown stock predictions 2021.
The company is likewise connected with Bonner & Partners, another well-respected research study publisher - exponential growth. On its website, Brownstone says its objective is to supply retail investors with professional-grade research: "For too long, the very best investment research study has not been readily available to individual financiers. It has actually been typically reserved for financial investment banks, hedge funds, private equity, and high-net-worth customers. jeff bezos. The objective of Brownstone Research is to make that kind of proprietary research study readily available to any financiers seeking to get an edge in the marketplaces. The goal is easy to deliver unique and lucrative investment research study found nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise functions as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After decades of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you know even a little bit about the market, you understand that he has a credibility as a King Midas of sorts. white house. Whatever he touches turns to gold! Jeff is well conscious of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In reality, Brown believes S.A.V. jeff brown top stock pick 2021. could be "the biggest trend of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying two cutting-edge innovations: synthetic intelligence and electrical cars. Musk hopes the combination will help him develop the very first fully-autonomous, self-driving cars and trucks ever. It's nothing except the automobile market's Holy Grail. As you understand, electrical cars and self-driving cars and truck stocks have actually been substantial this year, however the Wall Street device has actually been huge on hype without much tangible outcome. Despite an extreme boost in competition over the previous few years, Brown still thinks Musk has the very best possibility of putting everything together.
tech might be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Car, and it could be the future of transport. Generally, this technology would allow you to rent out your car as an autonomous, self-driving taxi when you're not utilizing it. You merely leave the car and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a significant piece of the earnings. It sounds crazy, however it could be closed than you think.